首页> Anti-cancer drugs> Evaluations of biomarkers associated with sensitivity to 5-fluorouracil and taxanes for recurrent/advanced breast cancer patients treated with capecitabine-based first-line chemotherapy

Evaluations of biomarkers associated with sensitivity to 5-fluorouracil and taxanes for recurrent/advanced breast cancer patients treated with capecitabine-based first-line chemotherapy

导出原文传递

翻译打印收藏纠错

第一作者： Zhao,H.-Y.

作者： Zhao,H.-Y. ^[1] ; Huang,H. ; Hu,Z.-H. ; Huang,Y. ; Lin,S.-X. ; Tian,Y. ; Lin,T.-Y.

作者单位： State Key Laboratory of Oncology in South China, Cancer Center, Sun Yat-Sen University, No. 651 ^[1]

关键词 capecitabine class III β-tubulin dihydropyrimidine dehydrogenase first-line chemotherapy recurrent/advanced breast cancer stathmin-1 or oncoprotein-18 taxanes thymidine phosphorylase thymidylate synthase

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览1

Anti-cancer drugs

2012年23卷5期

534-542页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览1

Anti-cancer drugs

2012年23卷5期

534-542页

检索历史清除

Evaluations of biomarkers associated with sensitivity to 5-fluorouracil and taxanes for recurrent/advanced breast cancer patients treated with capecitabine-based first-line chemotherapy

Anti-cancer drugs

相似文献

同项目论文

Anti-cancer drugs

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Evaluations of biomarkers associated with sensitivity to 5-fluorouracil and taxanes for recurrent/advanced breast cancer patients treated with capecitabine-based first-line chemotherapy

Anti-cancer drugs

相似文献

同项目论文

Anti-cancer drugs

相关期刊

检索历史清除